Cita APA

Lu, C., Lin, J., Chen, W., Lin, T., Jiang, J., Yang, S., . . . Teng, H. (2016). Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients. Oncotarget.

Chicago Style Citation

Lu, Chieh-Sheng, et al. "Intraperitoneal Ziv-aflibercept Effectively Manages Refractory Ascites in Colorectal Cancer Patients." Oncotarget 2016.

Cita MLA

Lu, Chieh-Sheng, et al. "Intraperitoneal Ziv-aflibercept Effectively Manages Refractory Ascites in Colorectal Cancer Patients." Oncotarget 2016.